Allakos Performance
| ALLKDelisted Stock | USD 0.33 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.11, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Allakos' returns are expected to increase less than the market. However, during the bear market, the loss of holding Allakos is expected to be smaller as well. Allakos right now shows a risk of 0.0%. Please confirm Allakos total risk alpha and the relationship between the value at risk and day median price , to decide if Allakos will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Allakos has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent essential indicators, Allakos is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors. ...more
| Begin Period Cash Flow | 67.9 M | |
| Free Cash Flow | -93.7 M |
Allakos |
Allakos Relative Risk vs. Return Landscape
If you would invest 33.00 in Allakos on October 6, 2025 and sell it today you would earn a total of 0.00 from holding Allakos or generate 0.0% return on investment over 90 days. Allakos is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Allakos, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Allakos Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Allakos' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Allakos, and traders can use it to determine the average amount a Allakos' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ALLK |
Based on monthly moving average Allakos is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Allakos by adding Allakos to a well-diversified portfolio.
Allakos Fundamentals Growth
Allakos Stock prices reflect investors' perceptions of the future prospects and financial health of Allakos, and Allakos fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Allakos Stock performance.
| Return On Equity | -0.89 | |||
| Return On Asset | -0.53 | |||
| Current Valuation | (46.92 M) | |||
| Shares Outstanding | 90.38 M | |||
| Price To Earning | (21.26) X | |||
| Price To Book | 0.54 X | |||
| EBITDA | (108.09 M) | |||
| Cash And Equivalents | 212.44 M | |||
| Cash Per Share | 3.87 X | |||
| Total Debt | 4.16 M | |||
| Debt To Equity | 0.23 % | |||
| Book Value Per Share | 0.61 X | |||
| Cash Flow From Operations | (93.62 M) | |||
| Earnings Per Share | (0.78) X | |||
| Total Asset | 96.6 M | |||
| Retained Earnings | (1.23 B) | |||
| Current Asset | 37.1 M | |||
| Current Liabilities | 3.08 M | |||
About Allakos Performance
By examining Allakos' fundamental ratios, stakeholders can obtain critical insights into Allakos' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Allakos is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company was incorporated in 2012 and is headquartered in Redwood City, California. Allakos operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 192 people.Things to note about Allakos performance evaluation
Checking the ongoing alerts about Allakos for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Allakos help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Allakos is not yet fully synchronised with the market data | |
| Allakos has some characteristics of a very speculative penny stock | |
| Allakos has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (115.82 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Allakos currently holds about 212.44 M in cash with (93.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 77.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Allakos' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Allakos' stock is overvalued or undervalued compared to its peers.
- Examining Allakos' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Allakos' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Allakos' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Allakos' stock. These opinions can provide insight into Allakos' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Allakos Stock
If you are still planning to invest in Allakos check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allakos' history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |